Photoacoustic (PA) computed tomography (PACT) is a non-invasive imaging technique offering optical contrast, high resolution, and deep penetration in biological tissues. PACT, highly sensitive to optical absorption by molecules, is inherently suited for molecular imaging using optically absorbing probes. Genetically encoded probes with photochromic behavior dramatically increase detection sensitivity and specificity of PACT through photoswitching and differential imaging. Starting with a DrBphP bacterial phytochrome, we have engineered a near-infrared photochromic probe, DrBphP-PCM, which is superior to the full-length RpBphP1 phytochrome previously used in differential PACT. DrBphP-PCM has a smaller size, better folding, and higher photoswitching contrast. We have also developed an advanced PACT technique, which combines the reversibly-switchable photochromic probes with single-impulse panoramic PACT, termed RS-SIP-PACT. Using RS-SIP-PACT, we have characterized DrBphP-PCM both in vitro and in vivo as an advanced near-infrared photochromic probe for PACT. We introduce two phytochromes into the same mammalian cells, resulting in a distinctive decay characteristic in comparison with the cells expressing DrBphP-PCM only. By discriminating the different decay characteristics, we successfully separate multiple cell types in deep tissues. The simple structural organization of DrBphP-PCM allows engineering a bimolecular PA complementation reporter, a split version of DrBphP-PCM, termed DrSplit. DrSplit enables PA detection of protein-protein interactions in deepseated mouse tumors and livers, achieving 125-µm spatial resolution and 530-cell sensitivity in vivo. The combination of RS-SIP-PACT with DrBphP-PCM and DrSplit holds great potential for non-invasive multi-contrast deep-tissue functional imaging.
INTRODUCTION
To better understand the molecular mechanisms and dynamics involved in physiology and disease in a whole organism, biomedical studies increasingly employ noninvasive whole-body imaging with high resolution in vivo [1] [2] [3] . Optical imaging offers valuable information and has been widely used in such studies [4] [5] [6] [7] . However, photons are strongly scattered in biological tissue, limiting high-resolution pure optical imaging to a penetration depth within the optical diffusion limit (~1 mm) [8] [9] [10] . Photoacoustic (PA) computed tomography (PACT), by acoustically detecting photons absorbed by tissue, breaks the resolution and depth limitations of pure optical imaging and provides high resolution imaging with optical contrast at depths up to centimeters [11] [12] [13] [14] . PACT, highly sensitive to optical absorption by molecules, is inherently suited for molecular imaging using optically absorbing probes. [15] [16] [17] [18] Genetically encoded probes are advantageous due to their harmless non-invasiveness, precisely controllable targeting, and tissue-specific promoters. The combination of PACT and a reversibly photoswitchable near-infrared (NIR) absorbing full-length bacterial phytochrome (BphP) from Rhodopseudomonas palustris, RpBphP1, has resulted in an advanced differential imaging technique, termed reversibly switchable PACT (RS-PACT). RS-PACT provided substantially enhanced detection sensitivity in deep tissues [19] in comparison with conventional PACT.
Structurally, BphP proteins consist of a photosensory core module (PCM) and various so-called effector domains (Fig.1a) . The PCM is formed by the PAS (Per-ARNT-Sim), GAF (cGMP phosphodiesterase/adenylate cyclase/FhlA), and PHY (phytochrome-specific) protein domains connected with α-helix linkers, and typically has a molecular weight of 55-58 kDa. The spectral properties of BphPs are determined by a covalently attached chromophore, biliverdin IXα (BV). Canonical natural BphPs have two absorbing states, one of which absorbs at 670-700 nm (the Pr state) and the other at 740-780 nm (the Pfr state). All BphPs exhibit natural photochromic behavior: they undergo reversible Pfr→Pr photoswitching upon 730-790 nm light irradiation and Pr→Pfr photoswitching upon 630-690 nm light irradiation. Here, we term the Pfr state of the BphP-based probes the "ON" state and the Pr state the "OFF" state.
Currently, because of the absence of PA probes with NIR absorbance, whole-body molecular imaging of proteinprotein interactions (PPIs) employs bioluminescent luciferases and FPs. PPI studies utilize Förster resonance energy transfer (FRET), bioluminescence energy transfer (BRET), and bimolecular fluorescence complementation (BiFC) approaches. However, relatively small changes in the FRET and BRET signals make these techniques suboptimal for use in whole mammals. BiFC is based on the tagging of two proteins of interest, each with half of an FP. Upon interaction of the proteins, the two halves of the split FP associate with each other to form a fluorescent complex with the complemented FP, thus reporting the PPIs. Recently, we engineered several BiFC reporters from NIR FPs and demonstrated their ability to detect PPIs in mice [20] . However, NIR BiFC did not provide high spatial resolution and sensitivity in imaging PPIs in deep tumors. PPIs were also imaged in vivo using split luciferase [21] and thymidine kinase [22] , resulting in bioluminescence and positron emission signals, respectively. However, these reporters require injection of substrates. Moreover, the emission of the most red-shifted split-luciferase is limited to 615 nm [23] , and thymidine kinase's signal provides low contrast and a non-specific background in vivo.
Here, we report a PACT technique which combines three approaches, namely single-impulse panoramic PACT (SIP-PACT) [2] , RS-PACT [19] , and real-time detection of the photoswitching rates of genetically encoded photochromic probes. We term this combined technique RS-SIP-PACT. We first measured the molar extinction coefficients for the ON states and the OFF states of DrBphP-PCM and RpBphP1. The ratios between the extinction coefficients of the ON state (Pfr form) at 780 nm and the OFF state (Pr form) at 630 nm of DrBphP-PCM and RpBphP1 were 9.9 and 4.1, respectively (Fig. 1b) . We employed 780 nm light for PA imaging and photoswitching the BphPs to the OFF state, and used 630 nm light to switch the BphPs back to the ON state. The laser fluence on the sample surface at both wavelengths did not exceed 12 mJ cm −2 , which is below the American National Standards Institute safety limit [24] . We next used RS-SIP-PACT to image U87 glioblastoma cells stably expressing either RpBphP1 or DrBphP-PCM. With the RS-SIP-PACT system, we imaged pure bovine blood and either RpBphP1 or DrBphP-PCM expressing U87 cells embedded in gelatin (Fig. 1c) . Temporal frequency lock-in PA reconstruction (LIR) successfully separated the PA signals from two BphPs from the non-photoswitchable blood signals. The decay constants from the ON to the OFF state enabled good separation of the blood and both types of U87 cells (Fig. 1d). 
RESULTS

Characterization of DrBphP-PCM
Multi-contrast RS-SIP-PACT imaging in vivo
We used RS-SIP-PACT to image the HEK-293 cells expressing both BphPs in equimolar quantities from a single plasmid and the U87 cells expressing only DrBphP-PCM. For each measurement voxel, we reasonably assumed that the local fluence was uniform within that voxel, because the 1/e optical penetration depth for NIR light is far greater than the voxel length. Experimental results showed that the photoswitching signals from HEK-293 cells expressing both BphPs contained two decay components, while the signals from U87 cells expressing DrBphP-PCM exhibited only one decay component, regardless of local fluence. In vitro experiments showed a good separation of the two types of cells (Fig.  2a) . To reliably separate the two types of tumors inside deep tissue in vivo, we applied this labeling strategy to the liver tumors. We first injected U87 cells expressing DrBphP-PCM (0.5×10 6 ) into the right lobe of the mouse liver and waited 5 days to allow the injected U87 cells to grow. After the waiting period, we injected HEK-293 cells expressing both BphPs (8×10 6 ) into the left lobe of the liver. At two hours post injection, we then imaged the tumor-bearing mouse (n = 3). The previous RS-PACT system required 1.6 s to form a cross-sectional image, which blurred whole-body images due to respiratory motion during data acquisition and thus reduced the detection sensitivity. In comparison, RS-SIP-PACT takes just 50 µs to form a cross-sectional image, with completely negligible motion artifacts. By taking advantage of this real-time imaging capability, RS-SIP-PACT can image the decays of both BphPs while monitoring the respiratory motion. Thus, LIR can highlight the tumors, with minimized motion artifacts and high contrast (Fig. 2b, c) . The signal decays from the tumors can be modeled in the form of 
RS-SIP-PACT imaging of PPIs with DrSplit
Using DrSplit and RS-SIP-PACT, we next longitudinally imaged PPIs in the tumors and monitored tumor metastases in the liver of mice. DrSplit-expressing MTLn3 cells ( 1×10 6 ) were first locally injected in the mouse liver. Fig. 3a shows the PACT image of the mouse liver on Day 32 after tumor cells injection but before rapamycin injection. The LIR image was overlaid on the anatomical image, but no lock-in frequency signal was detected. Then, rapamycin was injected through the tail vein ~40-44 h before the PA imaging. The LIR PA images highlighted the photoswitchable signals from the complemented DrSplit resulting from the PPIs (Fig. 3b) . And the tumor growth has been confirmed histologically (Fig. 3c) . We have also demonstrated an application of DrSplit as BiFC reporter at depths in vivo. We detected the fluorescence of reconstituted DrSplit after 32 days of tumor growth upon the induction of PPIs with rapamycin (Fig. 3d). 
DISCUSSION
PACT has demonstrated its capability for anatomical, functional, and molecular imaging. [25] [26] [27] [28] [29] [30] Particularly, for molecular imaging, PACT is well suited to take maximum advantage of the photochromic behavior of genetically encoded probes. [31, 32] Here, we combined the advanced RS-SIP-PACT technique with two distinct BphP-based probes, DrBphP-PCM and RpBphP1, which enabled multi-contrast PA in vivo imaging with a single 780 nm excitation. We then designed the first BiPC reporter, DrSplit, and by combining it with RS-SIP-PACT, photoacoustically detected PPIs with high spatial resolution in deep tissues at the whole-body level in mice. These advances resulted from the photochemical and structural features of DrBphP-PCM, which are superior to those of the previously used RpBphP1, as well as from the high imaging speed and the LIR approach of RS-SIP-PACT, which provided high-sensitivity, highresolution imaging at depths beyond those achievable by pure optical imaging [33] . 
